Cancer Treatment Research in Pennsylvania 3rd District (PA-03)

PA-03 × 93.395 without a Philadelphia cancer grade

Cancer Treatment Research meets Pennsylvania 3rd District (PA-03) on this page. $429,557,028.96 is the obligation sum on awards that carry both the CFDA 93.395 tag and congressional-district place of performance PA-03. It is not Pennsylvania’s statewide Cancer Treatment Research book, not the nationwide program total, and not a cancer-incidence ranking or a hospital oncology budget. Pennsylvania 3rd District is the district parent without this program filter. CFDA 93.395 is the program parent without the PA-03 filter. Correlation is not causation.

50 is an award-action count. Modifications can add rows. Unique recipients are unpublished, and this page will not invent contractors or award recipients. Dividing $429,557,028.96 by 50 yields about $8,591,140.58 per award, a ratio of two packet facts, not a typical R01 or a typical protocol year. FEC contribution tables do not fund these USAspending obligations. The catalog line is CANCER TREATMENT RESEARCH. Campus folklore is not a named-PI roster, and this page will not invent contractors.

Cancer Treatment Research as a USAspending.gov title

The official catalog title is CANCER TREATMENT RESEARCH. SpendingVault does not grade Pennsylvania 3rd District (PA-03) on Cancer Treatment Research, backlog, or policy. $429,557,028.96 is an obligation sum, not a verdict. CFDA 93.395 without the district filter is the national hub; this packet has no national total, so none is quoted. Other NCI or NIH institute listings remain outside $429,557,028.96.

NIH RePORTER, NCI program announcements, and clinical-trial registries are other series. They are not the 50 awards on USAspending.gov. Mixing a census from those files with this join would invent a per-unit dollar figure the packet does not support. NCI-campus and oncology-trial folklore is ordinary speech, not a packet field. Aging research on PA-12 is a different district stamp. This extract has no incidence table.

Pennsylvania 3rd District besides CFDA 93.395

Pennsylvania 3rd District (PA-03) is the geography side. Place of performance PA-03 is a coding field in the award file. It does not prove residency of beneficiaries, students, patients, or vendors. Pennsylvania federal spending is the statewide parent and includes other districts. Philadelphia speech does not locate every lab. Neighboring PA-02 NCI cells stay outside. A Cancer Treatment Research award tagged to PA-02 or NJ-01 is not here.

The district’s all-program obligation total is $11,205,842,981.38. $429,557,028.96 is the Cancer Treatment Research slice of that book, about 3.8%. Remaining district dollars sit with other CFDAs on Pennsylvania 3rd District, not inside this join. Quoting $429,557,028.96 as Pennsylvania 3rd District (PA-03)’s entire federal book would drop every other catalog line.

Fifty awards behind the PA-03 NCI total

50 awards against $429,557,028.96 implies about $8,591,140.58 per award. That mean is not a unit price and not a typical R01 or a typical protocol year. Research project awards and competing continuations can dominate dollars while the row count stays at 50. 50 rows can include continuations and amendments. Treat the count as records in an aggregate, not as 50 finished projects or 50 people. All spending ties lists other district-by-program pairs on the same obligation metric.

Research obligations versus invoices already paid

An obligation is a recorded commitment. An outlay is a payment from the Treasury. $429,557,028.96 is the commitment figure. This packet has no outlay total and no fiscal-year split, so none is invented. Citing the figure as cash already spent in Pennsylvania 3rd District (PA-03) over-reads the field. Do not rank Pennsylvania 3rd District (PA-03) as a winner or loser versus other districts. Keep both sides in the citation: Cancer Treatment Research (CFDA 93.395) and Pennsylvania 3rd District (PA-03).

Budget documents from Philadelphia and Pennsylvania appropriations answer other questions. They are not the source of this cell. If a chart mixes General Fund activity with CFDA 93.395 in PA-03, the chart has left the federal award series. The Center City and west-Philadelphia research belt as speech only did not receive $429,557,028.96 as a named metro in this packet.

How to cite the 93.395 × PA-03 pair

Cite: Cancer Treatment Research (CFDA 93.395) obligated $429,557,028.96 on 50 awards coded to Pennsylvania 3rd District (PA-03), per USAspending.gov. Keep both keys. Keep the word obligations. Open Pennsylvania 3rd District for the district rollup, CFDA 93.395 for the program rollup, Pennsylvania federal spending for Pennsylvania statewide spending, and All spending ties for other pairs. Later bulk files can move the dollars and the 50-award count; prefer those tables when the live overlay and this snapshot diverge. None of those links convert this cell into a cancer-incidence ranking or a hospital oncology budget, into outlays this packet omits, or into a contractor list.

Questions

How much Cancer Treatment Research funding is obligated in Pennsylvania 3rd District (PA-03)?

USAspending.gov records $429,557,028.96 in CFDA 93.395 obligations with Pennsylvania 3rd District (PA-03) place of performance across 50 awards. That is a program × district join, not an outlay and not Pennsylvania’s full federal total.

Do 50 awards mean 50 local trial, lab,s?

No. 50 is an award-action count and can include modifications. Unique recipients are unpublished. Average obligation is about $8,591,140.58 per award, a ratio of two packet facts, not a typical R01 or a typical protocol year.

Is this Pennsylvania 3rd District (PA-03)’s entire federal spending total?

No. $429,557,028.96 is only the Cancer Treatment Research slice tagged to Pennsylvania 3rd District (PA-03), about 3.8% of the district’s $11,205,842,981.38 all-program total. Pennsylvania federal spending is the statewide parent. Other CFDAs on Pennsylvania 3rd District sit outside this join.

Where are the live PA-03 and CFDA 93.395 tables?

Pennsylvania 3rd District is the district parent. CFDA 93.395 is the CFDA 93.395 hub. Pennsylvania federal spending is the Pennsylvania parent. All spending ties lists other pairs. Prefer those tables after later ingests; this page quotes 93.395 × PA-03 at $429,557,028.96.